Moore Capital Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-1,279,340
Closed -$14.6M – 635
2025
Q2
$14.6M Buy
1,279,340
+936,787
+273% +$10.6M 0.18% 100
2025
Q1
$4.63M Sell
342,553
-301,635
-47% -$5.01M 0.1% 191
2024
Q4
$10.9M Sell
644,188
-406,485
-39% -$7.91M 0.13% 165
2024
Q3
$21.3M Buy
1,050,673
+533,863
+103% +$10.9M 0.39% 68
2024
Q2
$11.7M Buy
516,810
+372,924
+259% +$9.77M 0.2% 121
2024
Q1
$3.78M Buy
143,886
+38,803
+37% +$1.11M 0.06% 224
2023
Q4
$3.31M Buy
+105,083
New +$2.85M 0.06% 192
2023
Q3
– Sell
-73,387
Closed -$2.71M – 512
2023
Q2
$2.71M Buy
+73,387
New +$2.24M 0.05% 225
2021
Q2
– Sell
-221,039
Closed -$6.17M – 826
2021
Q1
$6.17M Buy
+221,039
New +$5.88M 0.08% 214

Other funds holding CC

Moore Capital Management's CC Position: Q3 2025 in Review

Moore Capital Management sold out of Chemours (CC) in Q3 2025, closing a stake of 1,279,340 shares — an estimated $14.6M sold.

Moore Capital Management first reported a position in CC in Q1 2021 and held it in 9 quarters. The position peaked at $21.3M in Q3 2024. 428 funds tracked by Wall St. Rank hold CC as of Q3 2025.

  • Moore Capital Management reported no remaining Chemours position as of Q3 2025 after selling out during the quarter.
  • Moore Capital Management sold 1,279,340 Chemours shares in Q3 2025, an estimated $14.6M.
  • Moore Capital Management first reported a position in Chemours in Q1 2021 and held it in 9 quarters.
  • Moore Capital Management's Chemours position peaked at $21.3M in Q3 2024.
  • 428 funds tracked by Wall St. Rank held Chemours as of Q3 2025.

Based on Moore Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.